This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Neo Cremar Co.,ltd. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hye Jin Yang: Innovator in Muscular Disease Treatment
Introduction
Hye Jin Yang is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of muscular diseases. Her innovative work has led to the development of a unique composition that holds promise for improving muscle health.
Latest Patents
Hye Jin Yang holds a patent for a composition aimed at preventing or treating muscular diseases. This composition contains licorice extract or a compound isolated from it as an active ingredient. The patent describes a pharmaceutical composition and a health functional food composition that effectively induce myoblast proliferation and promote differentiation into myotubes. The licorice extract has shown excellent effects in regenerating damaged muscles, making it a valuable resource for preventing, improving, or treating various muscle diseases.
Career Highlights
Hye Jin Yang is currently associated with Neo Cremar Co., Ltd., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on practical applications that can benefit patients suffering from muscular diseases.
Collaborations
Hye Jin Yang collaborates with notable colleagues, including Won-Kyung Cho and Inho Choi. These partnerships enhance her research capabilities and contribute to the development of effective treatments.
Conclusion
Hye Jin Yang's contributions to the field of muscular disease treatment through her innovative patent highlight her role as a leading inventor. Her work not only showcases her expertise but also offers hope for improved health outcomes for individuals affected by muscular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile